PORT WASHINGTON, N.Y., Sept. 26, 2017 /PRNewswire/ -- Pall Corporation, a global leader in filtration, separation and purification,is pleased to announce the following new additions to the AllegroTM single-use chromatography and CadenceTM continuous bioprocessing product portfolios. Each product enables scalable process integration and intensification for biopharmaceutical
"A changing market has increased demand for drug manufacturers to innovate, thereby driving the need for critical automated end-to-end traditional and single-use process solutions. This is especially true as many manufacturers look to pursue the advantages of semi- or fully-continuous bioprocessing approaches," explained Martin Smith, Pall Chief Technology Officer. "The latest additions to our technology portfolio provide the support manufacturers need, and carry forward Pall's promise to bring continuous bioprocesses to life. We are happy to introduce these new technologies to the industry during BPI 2017 this week."
The Pall Life Sciences team is onsite at BPI 2017 through September 28 in booth #219 and #319. To request a meeting during the event, please email firstname.lastname@example.org. To learn more about how Pall Life Sciences supports the biopharmaceutical market, please visit: www.pall.com/biopharm.
About Pall CorporationPall Corporation is a filtration, separation and purification leader providing solutions to meet the critical fluid management needs of customers across the broad spectrum of life sciences and industry. Pall works with customers to advance health, safety and environmentally responsible technologies. The company's engineered products enable process and product innovation and minimize emissions and waste. Pall Corporation serves customers worldwide.
For more information visit www.pall.com.
Or follow us on social media: Google+ - YouTube - LinkedIn - Twitter - Facebook
Corporate Media ContactPall Corporation Mariann KourafasDirector of Communications+1-508-871-5469
Media ContactWhite Matter CommunicationsBeth Willers email@example.com +1-415-905-0324
View original content:http://www.prnewswire.com/news-releases/pall-life-sciences-introduces-new-continuous-and-single-use-technologies-for-scalable-bioprocess-optimization-300525585.html
SOURCE Pall Corporation
Subscribe to our Free Newsletters!
Water is essential to balance body fluids, boost brain function, improve digestion, prevent ...
Drug hypersensitivity is an adverse reaction that occurs due to an interaction between a drug and ...
Stiff joints are a major problem for the elderly, as the joints tend to wear-and-tear with ...View All